These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 6707933
1. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin. Simpson LL. J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933 [Abstract] [Full Text] [Related]
2. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. Bakry N, Kamata Y, Simpson LL. J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841 [Abstract] [Full Text] [Related]
3. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin. Simpson LL, Coffield JA, Bakry N. J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147 [Abstract] [Full Text] [Related]
4. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin. Simpson LL. J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911 [Abstract] [Full Text] [Related]
5. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins. Simpson LL. J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038 [Abstract] [Full Text] [Related]
6. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons. Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A. Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019 [Abstract] [Full Text] [Related]
9. The interaction between aminoquinolines and presynaptically acting neurotoxins. Simpson LL. J Pharmacol Exp Ther; 1982 Jul 02; 222(1):43-8. PubMed ID: 6283072 [Abstract] [Full Text] [Related]
10. Neuropharmacological characterization of fragment B from tetanus toxin. Simpson LL, Hoch DH. J Pharmacol Exp Ther; 1985 Jan 02; 232(1):223-7. PubMed ID: 3965693 [Abstract] [Full Text] [Related]
11. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships. Simpson LL, Dasgupta BR. J Pharmacol Exp Ther; 1983 Jan 02; 224(1):135-40. PubMed ID: 6294275 [Abstract] [Full Text] [Related]
12. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. Coffield JA, Bakry N, Zhang RD, Carlson J, Gomella LG, Simpson LL. J Pharmacol Exp Ther; 1997 Mar 02; 280(3):1489-98. PubMed ID: 9067339 [Abstract] [Full Text] [Related]
13. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity. Bakry N, Kamata Y, Sorensen R, Simpson LL. J Pharmacol Exp Ther; 1991 Aug 02; 258(2):613-9. PubMed ID: 1865360 [Abstract] [Full Text] [Related]
14. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. Simpson LL, Coffield JA, Bakry N. J Pharmacol Exp Ther; 1994 Apr 02; 269(1):256-62. PubMed ID: 8169833 [Abstract] [Full Text] [Related]